Literature DB >> 12539559

Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.

J Yi1, X Liao, Z Yang, X Li.   

Abstract

To study the changes in intratumoral microvessel density (MVD) in hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE), MVD in 42 HCC specimens histologically verified was studied by using immunohistochemical method. Of all the specimens, 20 were obtained from the patients treated with surgical resection alone, 22 from those with second stage surgical resection after TACE. The results showed that the MVD in HCC tissues was 53.4 +/- 21.9 in the TACE group and 27.6 +/- 9.2 in the single operating group, respectively, with the difference being significant between them (P < 0.001). It was suggested that TACE might contribute to angiogenesis of HCC, possibly due to anoxic stress and ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12539559     DOI: 10.1007/BF02886568

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

1.  Microvessel count predicts metastasis and prognosis in patients with gastric cancer.

Authors:  M Araya; M Terashima; A Takagane; K Abe; S Nishizuka; H Yonezawa; T Irinoda; T Nakaya; K Saito
Journal:  J Surg Oncol       Date:  1997-08       Impact factor: 3.454

2.  Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.

Authors:  T A Drixler; I H Borel Rinkes; E D Ritchie; T J van Vroonhoven; M F Gebbink; E E Voest
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

3.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis.

Authors:  H C Sun; Z Y Tang; X M Li; Y N Zhou; B R Sun; Z C Ma
Journal:  J Cancer Res Clin Oncol       Date:  1999-07       Impact factor: 4.553

4.  Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Authors:  M Prewett; J Huber; Y Li; A Santiago; W O'Connor; K King; J Overholser; A Hooper; B Pytowski; L Witte; P Bohlen; D J Hicklin
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.

Authors:  K W Kim; S K Bae; O H Lee; M H Bae; M J Lee; B C Park
Journal:  Cancer Res       Date:  1998-01-15       Impact factor: 12.701

6.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.

Authors:  N Tanigawa; C Lu; T Mitsui; S Miura
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

8.  Expression of vascular endothelial growth factor in human hepatocellular carcinoma.

Authors:  R Yamaguchi; H Yano; A Iemura; S Ogasawara; M Haramaki; M Kojiro
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

9.  Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization.

Authors:  N Kobayashi; M Ishii; Y Ueno; N Kisara; N Chida; T Iwasaki; T Toyota
Journal:  Liver       Date:  1999-02
  9 in total
  5 in total

1.  Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.

Authors:  A Lam; D Fernando; C C Sirlin; M Nayyar; S C Goodwin; D K Imagawa; C Lall
Journal:  Clin Radiol       Date:  2017-08-02       Impact factor: 2.350

2.  Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model.

Authors:  Jun-Gong Zhao; Gan-Sheng Feng; Xiang-Quan Kong; Xin Li; Ming-Hua Li; Ying-Sheng Cheng
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

3.  Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization.

Authors:  Zhen Li; Dao-Yu Hu; Qian Chu; Jian-Hong Wu; Chun Gao; Yu-Qing Zhang; Yan-Rong Huang
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  Xiaofeng Liao; Jilin Yi; Xingrui Li; Zhifang Yang; Wei Deng; Geng Tian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

5.  Prognostic significance of XRCC4 expression in hepatocellular carcinoma.

Authors:  Jun Lu; Xing-Zhizi Wang; Tian-Qi Zhang; Xiao-Ying Huang; Jin-Guang Yao; Chao Wang; Zhong-Hong Wei; Yun Ma; Xue-Min Wu; Chun-Ying Luo; Qiang Xia; Xi-Dai Long
Journal:  Oncotarget       Date:  2017-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.